Skip to content

Evaluation of a Psychosocial Support Model for Adolescents and Young Adults Newly Diagnosed With Cancer

Evaluation of a Psychosocial Support Model for Adolescents and Young Adults Newly Diagnosed With Cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06979843
Enrollment
142
Registered
2025-05-20
Start date
2025-01-16
Completion date
2028-12-01
Last updated
2026-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Brief summary

Rational: Adolescents and young adults (AYAs) newly diagnosed with cancer is a small but vulnerable group with many psychosocial needs persisting for a long time. No standardized psychosocial support program exists for this group of patients in Sweden. The program: The program in the present project aims at offering all AYAs, newly diagnosed with cancer, at two Comprehensive Cancer Centres in Sweden, an individual information meeting with a "Team Young" to assess psychosocial needs and then offer available psychosocial support including a structured psychosocial program labelled Promoting Resilience in Stress Management (PRISM). PRISM aims to strengthen key resilience resources such as stress-management, goal setting, cognitive reframing, and meaning-making. It has been developed and evaluated in the US. Evaluations from the US have proven to be promising among AYAs with cancer. PRISM was associated with clinically and statistically significant improvements in resilience, hope, benefit-finding, disease-related quality of life, and reductions in psychological distress, compared to usual care. Our research group has translated and adopted PRISM to a Swedish context with a participatory research approach involving clinicians, researchers, and end-users. The first version of PRISM has been evaluated in a feasibility study and based on the findings revised. A second feasibility study was finalised during 2024 at two Comprehensive Cancer Centers in Sweden with preliminary findings indicating positive experiences from participants. In parallel to this project, comparison data on primary and secondary outcomes, has been collected from the general population in the same age group. The findings indicate so far promising psychometric properties for the main outcome resilience. Aim: The overall aim of this research project is to evaluate a psychosocial support program for adolescents and young adults (AYAs) newly diagnosed with cancer. It includes offering all AYAs, newly diagnosed with cancer, an information meeting with a "Team Young" to assess psychosocial needs and then offer available psychosocial support including a structured psychosocial program labelled Promoting Resilience in Stress Management (PRISM). Method: The design is a longitudinal cohort study and will include approximately 130 AYAs (16-30 years) newly diagnosed with cancer at Karolinska- and Sahlgrenska University Hospitals. All participants will complete questionnaires on three occasions: at enrolment in PRISM, after 4 modules in PRISM and six months after enrolment. The primary outcome measure is psychological resilience and secondary outcomes are psychological well-being, quality of life and level of hope. Relevance: Implementing a structured psychosocial support program for AYAs newly diagnosed with cancer has the potential to mean a lot for each patient and their families and facilitate for health care professionals involved in their cancer care. If this research project shows promising results on resilience, psychological wellbeing, quality of life and/or hope, PRISM can be implemented as standard care at hospitals in Sweden treating AYAs with cancer.

Interventions

OTHERA psychosocial model

The first aim is to evaluate if participating in the psychosocial model (including Team Young and PRISM) maintains or improves psychological resilience, psychological wellbeing, quality of life and hope among AYAs at a six-month follow-up, compared to time of diagnosis. The second aim is to evaluate how participants in the model of psychosocial support (including Team Young and PRISM) experience it with regard to acceptability, relevance and benefit. The design is a longitudinal cohort study.

Sponsors

Karolinska Institutet
Lead SponsorOTHER
Sophiahemmet University
CollaboratorOTHER
Vastra Gotaland Region
CollaboratorOTHER_GOV
Region Stockholm
CollaboratorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

The research design follows the framework for developing and evaluating complex interventions, applying a non-randomised design since the project aims at aligning as closely as possible to the clinical practice and everyday routine. Further, when an evidence-based intervention is implemented in another setting to wherein it was previously found to be effective, it is reasonable to evaluate both the intervention as well as the implementation process part. It is essential to include a process evaluation to be able to investigate aspects beyond effectiveness. A process evaluation can shed light on fidelity and quality of implementation, how is change produced and how is context affecting the implementation.

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

for patients: * Participants will be AYAs newly diagnosed with cancer at Karolinska University Hospital and Sahlgrenska University Hospital who have been referred to Team young by their contact nurse. * Individuals newly diagnosed with cancer, 16-30 years of age who understand and speak Swedish.

Exclusion criteria

for patients: \- Any psychiatric disorder or cognitive difficulties. Inclusion criteria for health care professionals: \- Participants will be all eligible health care professionals, involved in delivering the implemented model of psychosocial support (Team Young and PRISM) at Karolinska University Hospital and Sahlgrenska University Hospital.

Design outcomes

Primary

MeasureTime frameDescription
ResilienceData collection implies all participants to complete questionnaires on three occasions: at enrolment in the study, after module 4 in PRISM (approximately 4-8 weeks after enrolment) and six months after enrolment in PRISM.The primary outcome, i.e. resilience will be measured with the Connor-Davidson Resilience Scale (CD-RISC-10 items). Score range is 0-40 for CD-RISC-10, with higher scores indicating greater resilience

Countries

Sweden

Contacts

CONTACTJeanette Winterling, PhD, Associate professor, RN
jeanette.winterling@regionstockholm.se+46 70-0856552
CONTACTAnna Jervaeus, PhD, Associate Professor, RN
anna.jervaeus@ki.se+46 70 264 2039
PRINCIPAL_INVESTIGATORJeanette Winterling

Region Stockholm

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 10, 2026